Está en modo consejo Apagar
Para moverse rápido entre los bloques

Organización: NewAmsterdam Pharma
LEI 984500B6549TF6E14D36

Nombre de la empresa
NewAmsterdam Pharma Co NV
Nombre del país
Países Bajos
País de registro
Países Bajos
Industria
Fabricación de medicina y biotecnología
Deuda de bonos
-

explore la más completa base de datos

800 000

bonos globalmente

Más de 400

fuentes de precios

80 000

acciones

9 000

ETF

siga su portfolio de la manera más eficiente
búsqueda de bonos
Watchlist
Excel ADD-IN
Obtener el acceso

Últimos datos al

Cotizaciones

Consulta enviada
Acceso denegado
Enviar consulta
Cotizaciones facilitadas por los proveedores de la información son indicativas

Perfil

NewAmsterdam Pharma operates as a pharmaceutical company. The Company focuses on the research and development of transformative therapies for cardio-metabolic diseases. NewAmsterdam Pharma serves customers in the Netherlands.

Premios

Noticias

28/03/2024 NewAmsterdam Pharma: , Including Exhibit 99.1, Is Being Furnished And Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liability Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act Of 1933, As Amended (the Securities Act ). The Information Contained In This Item 7.01, Including Exhibit 99.1, Shall Not Be Incorporated By Reference Into Any Registration Statement Or Other Document Pursuant To The Securities Act Or Into Any Filing Or Other Document Pursuant To The Exchange Act, Except As Otherwise Expressly Stated In Any Such Filing, Financial Statements And Exhibits
04/03/2024 NewAmsterdam Pharma: , Including Exhibit 99.1, Is Being Furnished And Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liability Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act Of 1933, As Amended (the Securities Act ). The Information Contained In This Item 7.01, Including Exhibit 99.1, Shall Not Be Incorporated By Reference Into Any Registration Statement Or Other Document Pursuant To The Securities Act Or Into Any Filing Or Other Document Pursuant To The Exchange Act, Except As Otherwise Expressly Stated In Any Such Filing, Financial Statements And Exhibits
28/02/2024 NewAmsterdam Pharma: Of This Current Report On Form, Financial Statements And Exhibits
13/02/2024 NewAmsterdam Pharma: The Information Contained In This Item 7.01, Including Exhibits 99.1 And 99.2, Is Being Furnished And Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended (the Exchange Act ), Or Otherwise Subject To The Liability Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act. The Information Contained In This Item 7.01, Including Exhibits 99.1 And 99.2, Shall Not Be Incorporated By Reference Into Any Registration Statement Or Other Document Pursuant To The Securities Act Or Into Any Filing Or Other Document Pursuant To The Exchange Act, Except As Otherwise Expressly Stated In Any Such Filing, Financial Statements And Exhibits
22/01/2024 NewAmsterdam Pharma: Regulation Fd Disclosure, Financial Statements And Exhibits
Todas las noticias de la organización

Documentos

Estados Financieros NIIF / US GAAP

2023
IV cuatr. inglés
2022
IV cuatr. inglés
Mostrar todo Ocultar
Es necesario autorizarse
Es necesario obtener acceso

Acciones

Deuda en bonos según divisa

Mostrar todo Ocultar

Códigos

  • LEI
    984500B6549TF6E14D36
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001936258

Calificaciones de riesgo y de ESG

Macroeconomía

Hay que registrarse para recibir el acceso.